Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saltman, D C
Right arrow Articles by Whicker, S D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saltman, D C
Right arrow Articles by Whicker, S D
Postgraduate Medical Journal 2005;81:474-480
© 2005 Fellowship of Postgraduate Medicine


ORIGINAL ARTICLE

Co-morbidity in general practice

D C Saltman 1, G P Sayer 2, S D Whicker 3

1 Discipline of General Practice, University of Sydney, Australia
2 Product Strategy and Research, Health Communication Network, Australia
3 Clinical Pharmacologist, Australia

Correspondence to:
Correspondence to:
Professor D C Saltman
Discipline of General Practice, University of Sydney, 37A Booth Street, Balmain 2041, NSW, Australia; deborah{at}gp.med.usyd.edu.au

Background: Co-morbidity, or the presence of more than one clinical condition, is gaining increased attention in epidemiological and health services research. However, the clinical relevance of co-morbidity has yet to be defined. In general practice, few studies have been conducted into co-morbidity, either at a single health care encounter, an episode of care, or for a defined time period.

Aims: To describe the major co-morbidity cluster profiles recorded by general practitioners. Another aim of this study is to describe the common clusters of co-prescribing.

Methods and results: Twelve month data from patients attending 156 GPs from 95 practices around a six month period of January to June 2003 were analysed. This represented 840 961 encounters from about 200 000 individual patients at these participating practices. Co-morbidity and co-prescribing cluster profiles are represented by problems managed and reasons for prescribing for the top 10 presentations and top 10 prescribed drugs in the study period.

Conclusions: By analysing the 10 most prevalent problems and 10 most prevalent drugs prescribed in consultations in a community sample, other co-morbidities that are particular to general practice, for example hypertension and lipid disorders, can be uncovered. Whether these clusters are causally related or occur by chance requires further analysis.


Keywords: comorbidity; general practice; prescribing; multimorbidity




This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
B van Bussel, E Pijpers, I Ferreira, P Castermans, and A N. Kruseman
Polymorbidity in diabetes in older people: consequences for care and vocational training
Postgrad. Med. J., December 1, 2007; 83(986): 763 - 767.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 The Fellowship of Postgraduate Medicine